Samantha Pearce Jazz Pharmaceuticals PLC (JAZZ) insider trading activity
Samantha Pearce is EVP, Chief Commercial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 40,815 shares of JAZZ, which is worth approximately $5.25 Million. The most recent transaction as insider was on Jul 12, 2022, when has been sold 532 shares (Ordinary Shares) at a price of $109.45 per share, resulting in proceeds of $58,227. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
40.8K
1.0%
3M change
69.51%
12M change
Total Value Held
$5.25 Million
Samantha Pearce Transaction History
SP
Samantha Pearce
EVP, Chief Commercial Officer
Dublin 4, L2